Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Integration of stable carbon isotope, microbial community, dissolved hydrogen gas, and ²HH₂O tracer data to assess bioaugmentation for chlorinated ethene degradation in fractured rocks.

Révész KM, Lollar BS, Kirshtein JD, Tiedeman CR, Imbrigiotta TE, Goode DJ, Shapiro AM, Voytek MA, Lacombe PJ, Busenberg E.

J Contam Hydrol. 2014 Jan;156:62-77. doi: 10.1016/j.jconhyd.2013.10.004. Epub 2013 Nov 2.

PMID:
24270158
2.

Inhibition of microsomal cortisol production by (-)-epigallocatechin-3-gallate through a redox shift in the endoplasmic reticulum--a potential new target for treating obesity-related diseases.

Szelényi P, Révész K, Konta L, Tüttõ A, Mandl J, Kereszturi É, Csala M.

Biofactors. 2013 Sep-Oct;39(5):534-41. doi: 10.1002/biof.1095. Epub 2013 Mar 29.

PMID:
23554216
3.

Luminal accumulation of newly synthesized morphine-3-glucuronide in rat liver microsomal vesicles.

Révész K, Tóth B, Staines AG, Coughtrie MW, Mandl J, Csala M.

Biofactors. 2013 May-Jun;39(3):271-8. doi: 10.1002/biof.1067. Epub 2012 Dec 22.

PMID:
23281118
4.

Monitoring biodegradation of ethene and bioremediation of chlorinated ethenes at a contaminated site using compound-specific isotope analysis (CSIA).

Mundle SO, Johnson T, Lacrampe-Couloume G, Pérez-de-Mora A, Duhamel M, Edwards EA, McMaster ML, Cox E, Révész K, Sherwood Lollar B.

Environ Sci Technol. 2012 Feb 7;46(3):1731-8. doi: 10.1021/es202792x. Epub 2012 Jan 19.

PMID:
22201221
5.

Inhibition of glycoprotein synthesis in the endoplasmic reticulum as a novel anticancer mechanism of (-)-epigallocatechin-3-gallate.

Konta L, Száraz P, Magyar JÉ, Révész K, Bánhegyi G, Mandl J, Csala M.

Biofactors. 2011 Nov-Dec;37(6):468-76. doi: 10.1002/biof.189. Epub 2011 Dec 8.

PMID:
22162335
6.

Tea flavan-3-ols as modulating factors in endoplasmic reticulum function.

Révész K, Tütto A, Szelényi P, Konta L.

Nutr Res. 2011 Oct;31(10):731-40. doi: 10.1016/j.nutres.2011.09.008. Review.

PMID:
22074797
7.

Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1.

Gorny MK, Wang XH, Williams C, Volsky B, Revesz K, Witover B, Burda S, Urbanski M, Nyambi P, Krachmarov C, Pinter A, Zolla-Pazner S, Nadas A.

Mol Immunol. 2009 Feb;46(5):917-26. doi: 10.1016/j.molimm.2008.09.005. Epub 2008 Oct 25.

8.

[Effect of green tea flavonols on the function of the endoplasmic reticulum].

Révész K, Tüttô A, Konta L.

Orv Hetil. 2007 Oct 7;148(40):1903-7. Review. Hungarian.

PMID:
17905686
9.

Glucuronide transport across the endoplasmic reticulum membrane is inhibited by epigallocatechin gallate and other green tea polyphenols.

Révész K, Tütto A, Margittai E, Bánhegyi G, Magyar JE, Mandl J, Csala M.

Int J Biochem Cell Biol. 2007;39(5):922-30. Epub 2007 Jan 20.

PMID:
17317271
10.

Cross-clade neutralizing activity of human anti-V3 monoclonal antibodies derived from the cells of individuals infected with non-B clades of human immunodeficiency virus type 1.

Gorny MK, Williams C, Volsky B, Revesz K, Wang XH, Burda S, Kimura T, Konings FA, Nádas A, Anyangwe CA, Nyambi P, Krachmarov C, Pinter A, Zolla-Pazner S.

J Virol. 2006 Jul;80(14):6865-72.

11.

[Anemia and iron metabolism in patients with type-2 diabetes mellitus].

Kovács F, Szakál I, Révész K, Lévai A, Dobos A.

Orv Hetil. 2006 Feb 26;147(8):345-9. Hungarian.

PMID:
16579333
12.

Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles.

Gorny MK, Stamatatos L, Volsky B, Revesz K, Williams C, Wang XH, Cohen S, Staudinger R, Zolla-Pazner S.

J Virol. 2005 Apr;79(8):5232-7.

13.

The cross-clade neutralizing activity of a human monoclonal antibody is determined by the GPGR V3 motif of HIV type 1.

Zolla-Pazner S, Zhong P, Revesz K, Volsky B, Williams C, Nyambi P, Gorny MK.

AIDS Res Hum Retroviruses. 2004 Nov;20(11):1254-8.

PMID:
15588347
14.

The v3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope.

Gorny MK, Revesz K, Williams C, Volsky B, Louder MK, Anyangwe CA, Krachmarov C, Kayman SC, Pinter A, Nadas A, Nyambi PN, Mascola JR, Zolla-Pazner S.

J Virol. 2004 Mar;78(5):2394-404.

16.

Comparison of delta18O measurements in nitrate by different combustion techniques.

Révész K, Böhlke JK.

Anal Chem. 2002 Oct 15;74(20):5410-3.

PMID:
12403600
17.

Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades.

Gorny MK, Williams C, Volsky B, Revesz K, Cohen S, Polonis VR, Honnen WJ, Kayman SC, Krachmarov C, Pinter A, Zolla-Pazner S.

J Virol. 2002 Sep;76(18):9035-45.

18.

Characterization of human monoclonal antibodies selected with a hypervariable loop-deleted recombinant HIV-1(IIIB) gp120.

Jeffs SA, Gorny MK, Williams C, Revesz K, Volsky B, Burda S, Wang XH, Bandres J, Zolla-Pazner S, Holmes H.

Immunol Lett. 2001 Dec 3;79(3):209-13.

PMID:
11600200
19.

Effect of soluble CD4 on exposure of epitopes on primary, intact, native human immunodeficiency virus type 1 virions of different genetic clades.

Mbah HA, Burda S, Gorny MK, Williams C, Revesz K, Zolla-Pazner S, Nyambi PN.

J Virol. 2001 Aug;75(16):7785-8.

20.

Atomic force microscopic study of the human cornea following excimer laser keratectomy.

Nógrádi A, Hopp B, Révész K, Szabó G, Bor Z, Kolozsvari L.

Exp Eye Res. 2000 Mar;70(3):363-8.

PMID:
10712822
21.

Effects of oligomerization on the epitopes of the human immunodeficiency virus type 1 envelope glycoproteins.

Gorny MK, VanCott TC, Williams C, Revesz K, Zolla-Pazner S.

Virology. 2000 Feb 15;267(2):220-8.

22.

Determination of δ(18)O and δ(15)N in Nitrate.

Révész K, Böhlke JK, Yoshinari T.

Anal Chem. 1997 Nov 1;69(21):4375-80. doi: 10.1021/ac9610523.

PMID:
21639170
23.

Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: role of glycosylation in the correct folding of the V1/V2 domain.

Wu Z, Kayman SC, Honnen W, Revesz K, Chen H, Vijh-Warrier S, Tilley SA, McKeating J, Shotton C, Pinter A.

J Virol. 1995 Apr;69(4):2271-8.

24.

[Therapeutic use of dapsone in dermatitis herpetiformis (Duhring) and in certain inflammatory skin diseases].

Révész K, Schneider I.

Orv Hetil. 1995 Jan 8;136(2):59-62. Review. Hungarian.

PMID:
7862431
26.

Continuous 500,000-year climate record from vein calcite in devils hole, nevada.

Winograd IJ, Coplen TB, Landwehr JM, Riggs AC, Ludwig KR, Szabo BJ, Kolesar PT, Revesz KM.

Science. 1992 Oct 9;258(5080):255-60.

PMID:
17835123
27.

Identification of large glycosylated proteins recognized by monoclonal antibodies against HIV-1 gag proteins.

Pinter A, Honnen WJ, Revesz K, Herz R.

AIDS Res Hum Retroviruses. 1992 Aug;8(8):1341-4. No abstract available.

PMID:
1466953
29.

[Hazards in borate therapy of infants].

REVESZ K.

Gyermekgyogyaszat. 1955 May;6(5):129-31. Hungarian. No abstract available.

PMID:
13241854
30.

[ACTH therapy of Leiner's diseases in infants].

REVESZ K.

Gyermekgyogyaszat. 1954 Jul;5(7):224. Hungarian. No abstract available.

PMID:
13221112
31.

[Kernicterus due to ABO incompatibility].

REVESZ K, VINCE I, BACKHAUSZ R.

Gyermekgyogyaszat. 1953 Jul;4(7):220-3. Undetermined Language. No abstract available.

PMID:
13095836
32.

[A case of acquired hemolytic anemia with autoagglutination in early infancy].

REVESZ K, VINCE I, BACKHAUS R.

Gyermekgyogyaszat. 1953 Jun;4(6):185-8. Undetermined Language. No abstract available.

PMID:
13084026
33.

[Observations on infant dyspepsia].

VEGHELYI P, VINCE I, REVESZ K, SZEKELY A, BENDZSEL R, FURESZ I, KUBINYI J.

Gyermekgyogyaszat. 1953 Apr;4(4):97-104. Undetermined Language. No abstract available.

PMID:
13060762
34.

[Study of the hypophysis adrenal system in atrophic infants].

REVESZ K, VINCE I, MOLNAR A.

Gyermekgyogyaszat. 1953 Jan;4(1):20-3. Undetermined Language. No abstract available.

PMID:
13021620
35.

[Hemagglutinin formation in the newborn and infant].

VINCE I, REVESZ K, BACKHAUS R.

Gyermekgyogyaszat. 1952 Jan;3(1):18-22. Undetermined Language. No abstract available.

PMID:
14897267
36.

[Methemoglobinemia in the infant].

REVESZ K.

Gyermekgyogyaszat. 1952 Jan;3(1):15-7. Undetermined Language. No abstract available.

PMID:
14897266
37.

[Reticulo-endothelial system in infantile atrophy].

VINCE I, REVESZ K, MOLNAR A.

Gyermekgyogyaszat. 1951 Dec;2(12):363-6. Undetermined Language. No abstract available.

PMID:
14888016
38.

Akute Nebennierenblutungen (Waterhouse-friderichsen Syndrom).

LUKACS V, REVESZ K.

Paediatr Danub. 1949 Apr-May;5(5):274-82. Undetermined Language. No abstract available.

PMID:
18131823

Supplemental Content

Loading ...
Support Center